Shandong Weigao Group Medical Polymer Company Limited (FRA:UK2)

Market Cap	1.79B -44.1%
Revenue (ttm)	1.63B +2.3%
Net Income	196.32M -22.0%
EPS	0.04 -21.1%
Shares Out	n/a
PE Ratio	9.10
Forward PE	8.51
Dividend	0.03 (7.22%)
Ex-Dividend Date	Oct 21, 2025

Volume	n/a
Average Volume	3,681
Open	0.3832
Previous Close	0.3715
Day's Range	0.3832 - 0.3832
52-Week Range	0.3714 - 0.7650
Beta	n/a
RSI	39.57
Earnings Date	Mar 27, 2026

About FRA:UK2

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company’s medical device products include safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions; and ...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1988
• Employees: 13,307
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: UK2

Financial Performance

In 2025, FRA:UK2's revenue was 13.39 billion, an increase of 2.31% compared to the previous year's 13.09 billion. Earnings were 1.61 billion, a decrease of -21.99%.

Financial numbers in CNY